These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33055119)

  • 1. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).
    Söderström HK; Räsänen J; Saarnio J; Toikkanen V; Tyrväinen T; Rantanen T; Valtola A; Ohtonen P; Pääaho M; Kokkola A; Kallio R; Karttunen TJ; Pohjanen VM; Ristimäki A; Laine S; Sihvo E; Kauppila JH
    BMJ Open; 2020 Oct; 10(10):e039575. PubMed ID: 33055119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland.
    Kauppila JH; Ohtonen P; Karttunen TJ; Kokkola A; Laine S; Rantanen T; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T
    BMJ Open; 2019 Jan; 9(1):e024094. PubMed ID: 30782726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study.
    Kauppila JH; Ohtonen P; Rantanen T; Tyrväinen T; Toikkanen V; Pääaho M; Valtola A; Räsänen J; Kallio R; Sihvo E; Saarnio J; Karttunen TJ; Pohjanen VM; Ristimäki A; Laine S; Kokkola A
    BMJ Open; 2020 Oct; 10(10):e039574. PubMed ID: 33067296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014.
    Helminen O; Sihvo E; Gunn J; Sipilä JOT; Rautava P; Kytö V
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):107-113. PubMed ID: 31263881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative hemoglobin count and prognosis of esophageal cancer, a population-based nationwide study in Finland.
    Jokela EMK; Kauppila JH;
    Eur J Surg Oncol; 2022 Mar; 48(3):548-552. PubMed ID: 34420826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends in mortality of oesophageal cancer in Finland over 30 years.
    Sirviö VEJ; Räsänen JV; Kauppila JH
    Eur J Surg Oncol; 2023 Sep; 49(9):106905. PubMed ID: 37061405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
    Sunde B; Lindblad M; Malmström M; Hedberg J; Lagergren P; Nilsson M
    BMC Cancer; 2021 Nov; 21(1):1277. PubMed ID: 34836512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?
    Sihvo EI; Salminen JT; Rämö OJ; Salo JA
    Scand J Gastroenterol; 2000 Oct; 35(10):1082-6. PubMed ID: 11099062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial results of the oesophageal and gastric cancer registry from the Comunidad Valenciana.
    Escrig J; Mingol F; Martí R; Puche J; Trullenque R; Barreras JA; Asencio F; Aguiló J; Navarro JM; Alberich C; Salas D; Lacueva FJ;
    Cir Esp; 2017 Oct; 95(8):428-436. PubMed ID: 28807364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric conduit cancer after oesophagectomy for oesophageal cancer: incidence and clinical implications.
    Lee GD; Kim YH; Choi SH; Kim HR; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2014 May; 45(5):899-903. PubMed ID: 24157484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
    Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
    Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.
    Alderson D; Cunningham D; Nankivell M; Blazeby JM; Griffin SM; Crellin A; Grabsch HI; Langer R; Pritchard S; Okines A; Krysztopik R; Coxon F; Thompson J; Falk S; Robb C; Stenning S; Langley RE
    Lancet Oncol; 2017 Sep; 18(9):1249-1260. PubMed ID: 28784312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data.
    Stavrou EP; Ward R; Pearson SA
    BMC Health Serv Res; 2012 Nov; 12():384. PubMed ID: 23136982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015.
    van der Kaaij RT; Koemans WJ; van Putten M; Snaebjornsson P; Luijten JCHBM; van Dieren JM; Cats A; Lemmens VEPP; Verhoeven RHA; van Sandick JW
    Eur J Cancer; 2020 May; 130():23-31. PubMed ID: 32171106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan.
    Blaser MJ; Saito D
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):107-13. PubMed ID: 11981333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary gastric cancer in an oesophageal gastric graft after oesophagectomy.
    Yoon YS; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1181-4. PubMed ID: 21868245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in oesophago-gastric surgery in Scotland.
    Oniscu GC; Paterson-Brown S
    Surgeon; 2003 Feb; 1(1):51-7. PubMed ID: 15568427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.